[CDSCO insights](https://indusdesk.com/cdsco/insights/)

# Draft would ban two antibiotic groups for animal use

https://indusdesk.com/cdsco/insights/draft-would-ban-two-antibiotic-groups-for-animal-use/

Draft S.O. 4996(E) would prohibit the import, manufacture, sale and distribution of carboxypenicillins and phosphonic acid derivatives for animal use. The Ministry of Health and Family Welfare (Department of Health and Family Welfare) issued it on September 3, 2026. It applies to Import, manufacture, sale and distribution, for animal use, of the listed antimicrobials and their formulations.

CDSCO · September 3, 2026

Vishnu Gupta

S.O. 4996(E) is a draft notification of the Ministry of Health and Family Welfare (Department of Health and Family Welfare), dated September 3, 2026. It was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 4806, dated September 9, 2026. The Central Government issued it under section 26A of the Drugs and Cosmetics Act, 1940 (23 of 1940). It is a proposal, not a prohibition in force. CDSCO lists the same file under the title "Prohibition of manufacture, import, sale and distribution of Carboxypenicillins and Phosphonic acid derivatives for animal use", without the word draft.

The draft lists, for animal use, two groups of antibiotics and their formulations: (i) carboxypenicillins and (ii) phosphonic acid derivatives. It names no individual molecule. Its preamble says the Central Government is satisfied that it is necessary and expedient in the public interest to prohibit the import, manufacture, sale and distribution of these antimicrobial medicinal products for animal use. It gives two grounds: the use in animals of drug formulations containing them is likely to involve risk to humans, and safer alternatives for animal use are available. The draft was published after consultation with the Drugs Technical Advisory Board.

The draft will be taken into consideration on or after the expiry of thirty days from the date on which copies of the Gazette containing it are made available to the public. The Central Government will consider objections and suggestions received from any person within that period. They may be addressed to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Government of India, U-6, Work Hall- C Wing, First Floor, Kartavya Bhawan-1, New Delhi, 110001, or emailed to drugsdiv-mohfw@gov.in. The draft names no end date. Its e-Gazette ID, CG-DL-E-15092026-276218, and its digital signature date the copy September 15, 2026; thirty days counted from then end on October 15, 2026.

The draft does not say when a final prohibition would take effect or what would happen to stock already made or imported. It refers to animal use in general and does not separate one kind of animal from another. It cites no earlier notification. Its file number, F. No. X.11035/125/2024-DR, is the same as that of S.O. 4338(E) of September 23, 2025. That notification prohibited the import, manufacture, sale and distribution of 15 antibiotics or antibiotic groups, 18 antivirals and one antiprotozoal for animal use. Carboxypenicillins and phosphonic acid derivatives are not on that list.

The draft is signed by Pushpendra Rajput, Joint Secretary. On October 28, 2026, CDSCO's Gazette notifications list showed no final notification on it.

**Issued by**: Ministry of Health and Family Welfare (Department of Health and Family Welfare)

**Document**: S.O. 4996(E), draft notification under section 26A of the Drugs and Cosmetics Act, 1940

**Dated**: September 3, 2026

**Gazette**: Extraordinary, Part II, Section 3, Sub-section (ii), No. 4806, September 9, 2026

**Gazette ID**: CG-DL-E-15092026-276218; the e-Gazette copy is dated September 15, 2026

**Applies to**: Import, manufacture, sale and distribution, for animal use, of the listed antimicrobials and their formulations

**Listed**: Antibiotics: (i) Carboxypenicillins; (ii) Phosphonic acid derivatives

**Grounds**: Use in animals is likely to involve risk to humans; safer alternatives for animal use are available

**Consulted**: Drugs Technical Advisory Board

**Comment period**: Thirty days from the date copies of the Gazette are made available to the public; no end date is given. Counted from September 15, 2026, the date of the e-Gazette copy, thirty days end on October 15, 2026

**Send comments to**: Under Secretary (Drugs), Ministry of Health and Family Welfare, or drugsdiv-mohfw@gov.in

**Takes effect**: Not stated; the draft is not final

**Status**: No final notification on CDSCO's Gazette notifications list on October 28, 2026

**Signed by**: Pushpendra Rajput, Jt. Secy.

**File number**: F. No. X.11035/125/2024-DR

[The notification (draft, under section 26A of the Drugs and Cosmetics Act, 1940)](https://files.indusdesk.com/mohfw/notifications/2026/so-4996e.pdf) (PDF, 578 KB)

Source: [Gazette of India, CG-DL-E-15092026-276218](https://egazette.gov.in/WriteReadData/2026/276218.pdf).

Checked against the official copy on October 28, 2026.

- [CDSCO guide](https://indusdesk.com/cdsco/)

- [All CDSCO insights](https://indusdesk.com/cdsco/insights/)
